about
OSSI-PET: Open-Access Database of Simulated [(11)C]Raclopride Scans for the Inveon Preclinical PET Scanner: Application to the Optimization of Reconstruction Methods for Dynamic Studies.Simulation-based optimisation of the PET data processing for partial saturation approach protocols.A data driven method for estimation of B(avail) and appK(D) using a single injection protocol with [¹¹C]raclopride in the mouse.Motion correction of multi-frame PET data in neuroreceptor mapping: simulation based validation.Analysis of variance in neuroreceptor ligand imaging studies.Multi-atlas attenuation correction supports full quantification of static and dynamic brain PET data in PET-MR.4D PET iterative deconvolution with spatiotemporal regularization for quantitative dynamic PET imaging.Simulation and Validation in Brain Image Analysis.Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.SORTEO: Monte Carlo-based simulator with list-mode capabilities.Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease.Optimization of dynamic measurement of receptor kinetics by wavelet denoising.Deconvolution-based partial volume correction in Raclopride-PET and Monte Carlo comparison to MR-based method.Test-retest reproducibility of 18F-MPPF PET in healthy humans: a reliability study.Creation and application of a simulated database of dynamic [18f]MPPF PET acquisitions incorporating inter-individual anatomical and biological variability.A PET imaging study of 5-HT(1A) receptors in cat brain after acute and chronic fluoxetine treatment.Characterisation of partial volume effect and region-based correction in small animal positron emission tomography (PET) of the rat brain.In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes.[18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.NEMA NU 4-2008 validation and applications of the PET-SORTEO Monte Carlo simulations platform for the geometry of the Inveon PET preclinical scanner.Simultaneous scanning of two mice in a small-animal PET scanner: a simulation-based assessment of the signal degradation.Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT.Simulation-based evaluation of OSEM iterative reconstruction methods in dynamic brain PET studies.Assessment of a fast generated analytical matrix for rotating slat collimation iterative reconstruction: a possible method to optimize the collimation profile.Imaging capabilities of the Inveon SPECT system using single-and multipinhole collimators.Evaluation of three MRI-based anatomical priors for quantitative PET brain imaging.Development and validation of a rebinner with rigid motion correction for the Siemens PET-MR scanner: Application to a large cohort of [11C]-PIB scans.Voxel-based analysis of asymmetry index maps increases the specificity of 18F-MPPF PET abnormalities for localizing the epileptogenic zone in temporal lobe epilepsies.Validation of PET-SORTEO Monte Carlo simulations for the geometries of the MicroPET R4 and Focus 220 PET scanners.Realistic simulated MRI and SPECT databases. Application to SPECT/MRI registration evaluationPET-SORTEO: validation and development of database of Simulated PET volumesAssessment of brain surface extraction from PET images using Monte Carlo SimulationsPET-SORTEO: A Monte Carlo-Based Simulator With High Count Rate CapabilitiesMonte Carlo Simulation-Based Design Study of a LSO-LuAP Small Animal PET SystemSubtyping of circulating exosome-bound amyloid β reflects brain plaque depositionAnalytical positron range modelling in heterogeneous media for PET Monte Carlo simulationCardiac motion and spillover correction for quantitative PET imaging using dynamic MRIImproved quantification of amyloid burden and associated biomarker cut-off points: results from the first amyloid Singaporean cohort with overlapping cerebrovascular diseaseLongitudinal trajectory of Amyloid-related hippocampal subfield atrophy in nondemented elderlyLow dose positron emission tomography emulation from decimated high statistics: A clinical validation study
P50
Q30488928-7D7A10AF-80A2-4035-A5E4-071E4135FBCCQ30803128-1D87DD5F-D389-45CD-A033-197EC5618976Q30826809-63B960FB-9B3F-4001-BC99-C49A74403821Q33456336-162E046A-FF33-4CF6-AC21-6F26F0F32A39Q33999407-3CA7EF10-7F36-4CC5-9DE7-A144EA1FFFFCQ36274951-F518723F-7917-4419-B65E-4FFFA74863BBQ40830259-EA6C9743-1B49-4B12-83D4-05FCC4974DC3Q42426081-729512A6-1B85-4404-BC81-718E013C83F4Q43125929-2D41F3E4-BCCB-460B-B8F7-7A559B906D10Q44230883-CC52CD4D-5099-40C0-AEA5-35514BF00084Q45001337-78B72D83-E117-4510-8A17-5E0F8012F305Q46780701-11421C44-CBDF-4F10-9F41-2DFA18A99B4CQ46852484-C08E0F70-0776-4B17-B29B-9C755149A4CFQ48104473-AB316F30-DEE3-4101-B403-3BCA2897AB0FQ48363395-21550032-F21B-4DAE-99CF-65A236A73D2EQ48414942-1E7B5632-BA16-4412-92EB-34DFF5E975F3Q48630420-43F68533-F0A5-4880-A26B-72E0C9EE77DAQ48726745-7D8161DC-5D24-4EC0-BFB3-54FD24646BCEQ48823244-F50E84B8-EC43-4FFE-969A-BC3E86898D81Q48930006-5011D7E7-5C15-4388-96D9-923802237769Q48957107-20495EE7-C244-412C-B9E6-5AF18461BB1AQ50638860-F18B91A3-D763-4C3B-AE68-820A37E3A78EQ50895055-4E7BCAC3-4AE9-4E04-A7A9-EED47564F5F1Q50954783-8D860B1D-5385-4A31-803D-855AC3E5206BQ51166963-BFC34217-1118-42E9-8C77-9E632DE0F854Q51505464-36C86F35-D2E0-4DF0-8B1A-4FF3B2B80B56Q52589269-5D20760C-59D2-4817-9066-7AE8343E2BBCQ53262408-CD3A2428-1896-4951-B886-03965759F478Q53470306-97F0B353-B890-4BFE-8830-344095072F35Q57041954-15E4F749-2E8F-4DDF-A196-5305DD127970Q59844294-FBB5ECCE-1B5B-4F32-A795-0881EEB51CBEQ59844296-DC97FFE5-8EC6-40B1-A403-831FB7CE41FBQ60690793-893745A0-1845-4459-8FE4-A29C4209C1D0Q60690795-D0BA4A03-73E2-4407-B51B-64CAC0AA1847Q64116948-8DD7BC48-D892-4B1A-B8AF-0E5A906C5E24Q84072921-268D896A-8259-408E-9663-0DF36348CEB3Q90689728-732E494F-0AD7-4221-8DFE-D606CCE7B6EBQ92164440-BE141981-9A43-4DF1-8AA2-9CC8A1EE7221Q92685469-5CAADBBB-3F1E-4C96-84FD-6E43FC2276A6Q92722551-3E96DD58-1BC4-4FC5-AFC7-EEC4DA09624B
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anthonin Reilhac
@ast
Anthonin Reilhac
@en
Anthonin Reilhac
@es
Anthonin Reilhac
@nl
Anthonin Reilhac
@sl
type
label
Anthonin Reilhac
@ast
Anthonin Reilhac
@en
Anthonin Reilhac
@es
Anthonin Reilhac
@nl
Anthonin Reilhac
@sl
prefLabel
Anthonin Reilhac
@ast
Anthonin Reilhac
@en
Anthonin Reilhac
@es
Anthonin Reilhac
@nl
Anthonin Reilhac
@sl
P106
P1153
6603021965
P2456
P31
P496
0000-0002-9997-9540